Other transcription factors, such as c-Maf and AhR, also participate in T H 17 differentiation. AhR is known to control the expression of IL-21 and IL-22 and has an important role in T H 17 differentiation in vivo and in vitro [8] [9] [10] . Dysregulated population expansion of T H 17 cells has been linked to the development of tissue inflammation and autoimmunity; thus, several mechanisms are in place to control the generation and activity of T H 17 cells 1 . Although IL-2 and IL-21 belong to the same family of cytokines, they have opposing effects on T H 17 differentiation: IL-21 acts as a growth factor and supports the population expansion of T H 17 cells, whereas IL-2 inhibits T H 17 differentiation [11] [12] [13] [14] [15] . IL-2 limits T H 17 differentiation in vitro and in vivo by interfering with IL-6-dependent signaling events. IL-2 downregulates expression of the IL-6 receptor 13 and also triggers the replacement of STAT3 with STAT5 on target DNA-binding sites in the Il17a-Il17f locus and in other genes required for T H 17 differentiation 12, 15 and thus it interferes with the T H 17 transcriptional program. Therefore, for T H 17 differentiation to proceed unabated, IL-2 expression must be actively downregulated. The uptake of IL-2 by regulatory T cells (T reg cells) that express the transcription factor Foxp3 promotes T H 17 differentiation in vivo and in vitro 11, 14 . It is conceivable that in addition to the removal of IL-2 by cell-extrinsic mechanisms, cell-intrinsic mechanisms that actively limit the production of IL-2 are in place to promote T H 17 differentiation.
Here we report significant upregulation of Aiolos, a member of the Ikaros family of transcription factors, during T H 17 differentiation by a mechanism that involved STAT3 and AhR. Moreover, Aiolos bound to and silenced the Il2 locus, suppressing the production of IL-2 and promoting T H 17 differentiation in vitro and in vivo. Thus, our results identify a transcriptional module that actively limits the production of IL-2 during T H 17 differentiation to promote the development of T H 17 cells.
RESULTS

Expression of Aiolos by T H 17 cells
Our analysis of the transcriptional programs of CD4 + T cell subsets showed that T H 17 cells expressed Aiolos (encoded by Ikzf3; data not shown). We found that naive CD4 + CD25 − CD62L + CD44 lo T cells differentiated in vitro into T helper type 1 (T H 1) or T H 2 cells had modest expression of Ikzf3, but Ikzf3 expression was substantially upregulated in T H 17 cells differentiated with TGF-β1 plus IL-6 (Fig. 1a) . We did not detect upregulation of genes encoding other members of the Ikaros family of transcription factors, including Ikaros itself, Helios, Eos and Pegasus 16 , in differentiating T H 17 cells (Fig. 1b) .
A r t i c l e s
We also detected Ikzf3 expression in Foxp3 + T reg cells differentiated in vitro and T regulatory type 1 cells (Tr1 cells) induced with IL-27 ( Supplementary Fig. 1 ). The role of transcription factors of the Ikaros family in the differentiation of Foxp3 + T reg cells and Tr1 cells has been investigated [17] [18] [19] [20] ; thus, in this study we focused on the role of Aiolos in the differentiation of T H 17 cells. We first investigated the kinetics of Ikzf3 expression under T H 17-polarizing conditions. Ikzf3 expression was substantially upregulated 6 h after activation in the presence of TGF-β1 and IL-6, and its expression remained very high throughout the T H 17 differentiation (Fig. 1c) . Upregulation of Ikzf3 expression preceded the induction of Il17a (Fig. 1c) . The activation of T cells in the absence of polarizing cytokines (T H 0 conditions) did not result in substantial upregulation of Ikzf3 expression (Fig. 1c) . Together these data demonstrated that activation of naive CD4 + T cells under T H 17-polarizing conditions resulted in the upregulation of Ikzf3 expression.
Control of T H 17 differentiation by Aiolos
To determine if Aiolos has a role in the differentiation of T H 17 cells, we investigated the effect of loss of Aiolos on T H 17 differentiation using naive T cells from wild-type and Aiolos-deficient mice 21 . Naive Aiolosdeficient CD4 + T cells showed significant impairment in their differentiation into T H 17 cells, as shown by their lower expression of Il17a and other genes encoding molecules linked to the T H 17 lineage, such as Rorc, Rora, Maf, Ahr, Il17f and Il21, and diminished secretion of IL-17 into culture supernatants (Fig. 2a-c) . Retrovirus-mediated overexpression of Ikzf3 in T cells activated under non-T H 17-polarizing conditions did not result in upregulation of the expression of Rorc or Il17a ( Supplementary  Fig. 2 ), which suggested that Aiolos participated in but was not sufficient to induce T H 17 differentiation. Conversely, Aiolos-deficient CD4 + T cells produced more interferon-γ (IFN-γ) than wild-type cells did when activated under T H 1-polarizing conditions (Fig. 2b) .
To characterize the relevance of Aiolos to T H 17 differentiation during the course of an immune response, we studied the in vivo population expansion of T H 17 cells after immunization. We immunized naive wild-type and Aiolos-deficient mice with myelin oligodendrocyte peptide (amino acids 35-55 (MOG(35-55)) emulsified in complete Freund's adjuvant and, 7 d later, assessed the ability of lymph node cells to proliferate in response to MOG and produce IFN-γ and IL-17. Aiolos-deficient mice had a slightly lower recall proliferative response to MOG (Fig. 2d) and a significantly lower frequency of T H 17 cells immediately after isolation, concomitant with a greater proportion of T H 1 cells (Fig. 2e) .
To analyze the pathogenicity of Aiolos-deficient T H 17 cells, we used a model of passive transfer of experimental autoimmune encephalomyelitis (EAE). We immunized wild-type and Aiolos-deficient mice with MOG(35-55) and reactivated lymphocytes from the mice in vitro with MOG in the presence of IL-12 or IL-23 to favor the population expansion of pathogenic T H 1 cells or T H 17 cells, respectively. Aiolos-deficient T cells reactivated under T H 17-favoring conditions had significantly less ability to induce EAE after transfer into host mice deficient in recombination-activating gene 2 (Rag2 −/− mice; Fig. 2f) . Conversely, Aiolos-deficient T cells reactivated under T H 1-favoring conditions showed significantly more encephalitogenic activity (Fig. 2g) . Thus, Aiolos controlled the differentiation of encephalitogenic T cells. Together these data indicated that Aiolos participated in the differentiation of T H 17 cells and limited the generation of T H 1 cells in vitro and in vivo.
Aiolos limits IL-2 production in T H 17 cells IL-2 limits the differentiation of T H 17 cells in vitro and in vivo [11] [12] [13] [14] [15] . Several members of the Ikaros family have been shown to control the production of IL-2 in mouse T cells 18 and human T cells 17, 22 . Thus, we examined the expression of Il2 during T H 17 differentiation. After an initial peak, the expression of Il2 was silenced in T H 17 cells but not in T H 0 cells (Fig. 3a) . The arrest in Il2 transcription in T H 17 cells coincided with the upregulation of Il17a (Fig. 3a) , Rorc and Rora ( Supplementary  Fig. 3) . Conversely, the continued production of Il2 in T H 0 cells was concomitant with the increase in expression of Ifng (Fig. 3a) .
Given the inhibitory effects of IL-2 on T H 17 differentiation and the reported inhibitory effects of Ikaros proteins on the production of IL-2 by T cells 17, 18, 22 , we determined whether Aiolos promoted T H 17 differentiation by inhibiting the production of IL-2. Aiolosdeficient T cells activated under T H 17-polarizing conditions produced more IL-2 than did wild-type T cells activated in the same way ( Fig. 3b-d) , which correlated with less production of IL-17 by Aiolos-deficient cells (Fig. 3d) . IL-2 induces expression of the α-chain of the IL-2 receptor (CD25), presumably as a part of a positive feedback loop 23 . Accordingly, we found upregulation of Il2ra in Aiolos-deficient T cells activated under T H 17-polarizing conditions ( Supplementary Fig. 3b,c) . Thus, Aiolos-deficient T cells produced more IL-2 when activated under T H 17-polarizing conditions, and the autocrine effects of IL-2 upregulated expression of the high-affinity IL-2 receptor, which made these cells more sensitive to the biological effects of IL-2. We also observed more production of IL-2 (Fig. 3c) and a greater frequency of IL-2 + T cells (Supplementary Fig. 4a,b among naive Aiolos-deficient CD4 + T cells activated under T H 1-polarizing conditions than among wild-type CD4 + T cells activated under T H 1-polarizing conditions. In addition, Aiolos-deficient CD4 + T cells activated under T H 1-polarizing conditions had higher expression of Tbx21 (which encodes T-bet) and CD25 than wild-type cells activated under T H 1-polarizing conditions had ( Supplementary  Fig. 4c -e). Together these data suggested that Aiolos negatively regulated the production of IL-2. To determine whether the dysregulated production of IL-2 in Aiolosdeficient CD4 + T cells under T H 17-polarizing conditions was responsible for the diminished differentiation of these cells along the T H 17 pathway, we investigated the differentiation of wild-type and Aiolosdeficient naive T cells under T H 17 conditions in the presence of blocking antibody to IL-2 or isotype-matched control antibody. The antibody to IL-2 abrogated the deficit in the production of T H 17 cells by Aiolosdeficient T cells (Fig. 3e) , whereas a blocking antibody to IFN-γ had no substantial effect on the T H 17 differentiation of Aiolos-deficient cells (Supplementary Fig. 3d ). Those observations were in agreement with the lack of upregulation of Tbx21 in Aiolos-deficient T cells activated under T H 17-polarizing conditions ( Fig. 2c) and demonstrated that the diminished differentiation of Aiolos-deficient T cells into T H 17 cells in vitro did not result from the inhibitory effects of IFN-γ on T H 17 differentiation 24, 25 . Antibody to IL-2 abrogated the enhanced production of IFN-γ and the upregulation of Tbx21 and Il2ra in Aiolos-deficient T cells activated under T H 1-polarizing conditions ( Supplementary  Fig. 4f-h ). Together these data demonstrated that Aiolos promoted T H 17 differentiation by limiting the production of IL-2.
Silencing of the Il2 promoter by Aiolos in T H 17 cells
Members of the Ikaros family of transcription factors regulate IL-2 expression in mouse T cells 18 and human T cells 17, 22 by interacting with the locus encoding IL-2 and triggering epigenetic changes that limit its accessibility to other transcription factors. Thus, we searched the mouse Il2 promoter for Aiolos-binding sites and found a putative Aiolos-binding element 13 base pairs upstream of the transcription start site in the Il2 promoter (Fig. 4a) . To determine whether Aiolos bound to its putative target sequence in T H 17 cells, we used electrophoretic mobility-shift assay (EMSA) with a double-stranded oligonucleotide composed of the Aiolos-binding element in the Il2 promoter to probe nuclear extracts from T H 17, T H 1 or T H 0 cells differentiated in vitro. Nuclear extracts of T H 17 cells bound the putative Aiolos-binding site, but those of T H 0 or T H 1 cells did not (Fig. 4b) . The interaction between the radiolabeled oligonucleotide and the nuclear extracts of T H 17 cells was lower after preincubation with antibody to Aiolos but not after preincubation with control antibody to tubulin (Fig. 4b) . Antibodies to proteins of the Ikaros family disrupt the oligomeric form responsible for DNA binding in EMSA 26 , which suggests that Aiolos in the nuclear extracts of T H 17 cells interacted with its consensus binding element in the Il2 promoter. In addition, chromatin immunoprecipitation (ChIP) assays showed that Aiolos interacted with its binding site in the Il2 promoter in T H 17 cells but not in T H 1 or T H 0 cells (Fig. 4c) . Thus, Aiolos interacted with the Il2 promoter during T H 17 differentiation.
Transcription factors of the Ikaros family control the epigenetic status of their target genes 18, 22, 27 . Chromatin modifications have an important role in the regulation of gene expression; the presence of acetylated histone H3 (H3ac) and acetylated histone H4 (H4ac), and of histone H3 trimethylated at Lys4 (H3K4me3), has been linked to the active transcription of genes, whereas the presence of H3K9me3 or H3K27me3 is associated with the repression of gene expression 14 . Thus, to investigate the molecular basis of the suppression of Il2 containing the firefly luciferase gene under the control of the IL2 promoter into human Jurkat T cells. Transfection of this luciferase reporter together with a construct encoding Aiolos resulted in substantial and dose-dependent repression of the transcriptional activity of the IL2 promoter (Fig. 4f) . (Fig. 5a) . We detected phosphorylation of STAT3, which is known to control its own transcription as well as the expression of Rorc and Ahr in T H 17 cells 4,28,29 , as early as 5 min after the initiation of T H 17 differentiation (Supplementary Fig. 5 ). Genome-wide ChIP analyses have reported interaction of STAT proteins with the Ikzf3 locus 30 . Moreover, the transcription factor AhR is important in the development of T H 17 cells 8, 10 . Thus, to investigate the mechanisms that control Aiolos expression in T H 17 cells, we searched for STAT3-and AhR-binding sites in the mouse Ikzf3 promoter and found three putative STAT3-responsive elements and three putative AhR-binding sites (Fig. 5b) .
Transfection of expression vectors for Aiolos into Jurkat cells also induced inhibition of expression of endogenous IL2 (data not shown). Together these data demonstrated that Aiolos induced epigenetic modifications that silenced Il2 expression in T H 17 cells.
Control of Aiolos expression by AhR and STAT3 in T H 17 cells
Whole-genome ChIP analysis of RORγt followed by sequencing did not show enrichment in the binding of RORγt to the Ikzf3 promoter (data not shown). ChIP assays showed interaction of AhR (Fig. 5c) and STAT3 ( Fig. 5d) with their binding sites in the Ikzf3 promoter in T H 17 cells but not in T H 0 cells (used as a control) or when we used isotypematched control antibodies. To determine the functional consequences of the interaction of AhR and STAT3 with the Ikzf3 promoter in T H 17 cells, we assessed at the effect of AhR and STAT3 on transactivation of the IKZF3 promoter in luciferase reporter assays. Transfection of a reporter containing the firefly luciferase gene under the control of the IKZF3 promoter together with a construct encoding AhR or constitutively activated STAT3 into Jurkat T cells resulted in substantial transactivation of the IKZF3 promoter (Fig. 5e) .
Retrovirus-mediated overexpression of AhR in activated T cells resulted in small but significant upregulation of Ikzf3 expression and concomitantly lower Il2 expression (P < 0.05; Supplementary Fig. 6 ), which suggested that additional signaling pathways were needed to make the Ikzf3 locus accessible to AhR during T H 17 differentiation. To further investigate the role of AhR in the control of Ikzf3 expression, we used the AhR-specific ligand FICZ, which activates AhR in T H 17 cells 10, 31 . Activation of AhR with FICZ during T H 17 differentiation resulted in significant upregulation of Ikzf3 expression (Fig. 5f) . Conversely, inhibition of AhR signaling with the specific inhibitor CH-223191 led to significantly lower Ikzf3 expression during T H 17 differentiation (Fig. 5f) . We obtained similar results with Jurkat cells activated in the presence of FICZ or CH-223191 (data not shown). Together these data demonstrated that STAT3 and AhR regulated Ikzf3 expression in T H 17 cells.
Aiolos controls the generation of IL-17-producing memory T cells IL-2 has an important role in the phenotype and abundance of memory T cells 32 . Because our data showed that Aiolos limited the generation of T H 17 cells in vivo by silencing Il2 expression, we investigated the role of Aiolos in the generation of T H 17 cells under physiological conditions. We found a significantly greater frequency and quantity of CD62L lo CD44 hi CD4 + memory T cells in Aiolos-deficient mice than in wild-type mice (Fig. 6a-c) , which suggested that the population expansion and/or survival of memory T cells was enhanced in Aiolos-deficient mice. Moreover, Aiolosdeficient mice had a significantly lower frequency of IL-17 + CD4 + memory T cells (Fig. 6d,e) and lower RORγt expression in those cells (Fig. 6f) than did wild-type mice, concomitant with a greater frequency of IFN-γ-producing memory T H 1 cells and higher expression of Tbx21 in Aiolos-deficient mice than in wild-type mice (Fig. 6d-f) Rag2 −/− mice, but T H 17 cells do not 35 . IL-2 limits the differentiation of T H 17 cells in the gut 12, 15 ; thus, we investigated the role of Aiolos in the differentiation of gut T H 17 cells. We transferred naive wildtype or Aiolos-deficient CD4 + T cells into Rag2 −/− mice and analyzed the production of IL-17 and IFN-γ in recipient mice 1 month after that transfer. T cells isolated from the mesenteric lymph nodes of mice reconstituted with Aiolos-deficient T cells produced less IL-17 than did those from mice reconstituted with wild-type cells (Fig. 7a) . Consistent with our in vitro data, the diminished production of IL-17 was concomitant with enhanced production of IFN-γ and IL-2 (Fig. 7a) , which led to a significantly higher ratio of IFN-γ + cells to IL-17 + cells among CD4 + T cells (Fig. 7a,b) .
To assess the relevance of silencing of the Il2 locus by Aiolos in the context of inflammation, we studied the development of colitis in Rag2 −/− mice given adoptive transfer of CD4 + CD25 − CD45RB hi T cells. In this model, the transferred cells differentiate into T H 1 cells and T H 17 cells and drive the development of inflammatory colitis. IL-2 is colitogenic in this experimental model 36 , and increases in the ratio of T H 1 cells to T H 17 cells 37 have been linked to a more-severe wasting disease. We adoptively transferred purified CD4 + CD25 − CD45RB hi T cells from wild-type or Aiolos-deficient mice into Rag2 −/− mice. Recipients of Aiolos-deficient T cells developed a more-aggressive wasting disease than that of recipients of wildtype T cells, as shown by their accelerated weight loss (Fig. 7c,d ), shorter colons (Fig. 7e) and inflammatory histological scores (Fig. 7f) . The greater colitogenic activity of Aiolos-deficient T cells was linked to more production of IFN-γ and a higher ratio of IFN-γ + cells to IL-17 + cells in the CD3 + CD4 + T cell compartment of the lamina propria (Fig. 7g,h ) and less production of IL-17 by gut T cells (Fig. 7g) . We found no significant difference between recipients of wild-type or Aiolos-deficient T cells in their production of IL-22 or in the Foxp3 + T reg cell or IL-10 + T cell compartments ( Supplementary  Fig. 7a-c) . To determine whether the differences in disease induction were dose dependent, we transferred fewer purified CD4 + CD25 − CD45RB hi T cells from wild-type or Aiolos-deficient mice (1 × 10 5 cells per mouse) into Rag2 −/− mice. Even under these experimental conditions, in which the recipient mice required more time to develop wasting disease, the Aiolos-deficient T cells induced a more-severe , (a-c),(e-h) s.e.m.). 38 , our data would suggest that this is most probably achieved by the induction of Aiolos in these cells. Similarly, there is strict control of the production of IL-2 by T reg cells such that they are entirely dependent on exogenous IL-2 for population expansion. Aiolos 17 and Eos 18 , another member of the Ikaros family, participate in the control of endogenous IL-2 production in these cells.
IL-2 is a potent endogenous T cell-driven inhibitor of T H 17 differentiation, and IL-2 concentrations must be controlled to promote T H 17-type immunity 12, 13, 15 . In vivo, the availability of IL-2 (and consequently T H 17 differentiation) can be regulated by control of the production of IL-2 and/or its consumption. Foxp3 + T reg cells have been shown to promote T H 17 differentiation in vivo and in vitro by consuming IL-2 (refs. 11,14) . Our data have demonstrated that under T H 17-polarizing conditions, the production of IL-2 was limited by a T H 17 cell-intrinsic mechanism mediated by Aiolos. Thus, the silencing of Il2 expression by Aiolos complemented the consumption of IL-2 by Foxp3 + T reg cells to promote the differentiation of T H 17 cells during the course of an immune response. Moreover, the silencing of Il2 expression in T H 17 cells by Aiolos might be complemented by other mechanisms that operate in T cells to control the production of IL-2. One such mechanism is the inhibition of activation of the transcription factor NF-κB and Il2 expression by the transcription factors Foxo1 and Foxo3a, which have high expression in resting T cells and whose expression is partially controlled by STAT3 in activated T cells 39 .
IL-2 and its receptor have been genetically linked to many human and mouse autoimmune diseases. The development of type 1 diabetes in mice of the nonobese diabetic (NOD) strain shows linkage to the Idd3 locus, which includes Il2 (ref. 40) . NOD mice have less IL-2, an observation initially linked to diminished function of Foxp3 + T reg cells 40 . However, the lower expression of IL-2 in NOD mice is correlated with more circulating T H 17 cells 41 , which suggests that an imbalance in the production of IL-2 and its control over T H 17 differentiation, in addition to its effects on Foxp3 + T reg cells, has important consequences for the development of autoimmunity. Thus, in vivo, mechanisms that regulate Il2 expression might influence the development of autoimmunity at different levels. First, they can control the activity 40 and homeostasis 42 of Foxp3 + T reg cells. Second, they can regulate the generation of T H 17 cells and alter the balance between T H 1 cells and T H 17 cells 12, 13, 15, 39 (as shown here). Third, initial alterations in the balance between T H 1 cells and T H 17 cells might be amplified by the inhibitory effects of IFN-γ and IL-17 on T H 17 differentiation 24 and T H 1 differentiation 35 , respectively. IL-21 belongs to the IL-2 family of cytokines; however, IL-2 and IL-21 have opposite effects on T H 17 cells: IL-2 inhibits the differentiation of T H 17 cells 12 , whereas IL-21 promotes the generation and population expansion of T H 17 cells 3 . The Il2 and Il21 loci are in close proximity and are inherited as a haplotype on chromosome 3 in mice and chromosome 4 in humans; thus, it has been proposed that they might be regulated by competition for alternative use of regulatory elements 43 . We did not find binding sites for Ikaros proteins in the Il21 promoter (data not shown). On the surface, such findings might suggest that members of the Ikaros family of transcription factors do not regulate Il21 expression. However, AhR, which has high expression by T H 17 cells 10, 31 , transactivates both the Il2 promoter 44 and the Il21 promoter 45 . Therefore, it is possible that by restricting the accessibility of target DNA sequences in the Il2 promoter of T H 17 cells, Aiolos directs AhR to induce the expression of Il21 but not of Il2 in T H 17 cells.
In conclusion, we found that Aiolos participated in a transcriptional module in T H 17 cells that limited the autocrine inhibitory effects of IL-2 on T H 17 differentiation. This T H 17 cell-intrinsic mechanism of the regulation of IL-2 complemented the consumption of IL-2 by Foxp3 + T reg cells to promote T H 17 differentiation in vivo and in vitro. As T H 17 cells have an important role in the immune response to infection and autoimmune disorders 1 , characterization of the molecular mechanisms that control the development of T H 17 cells might provide new targets for the therapeutic manipulation of effector T cell responses.
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